The National Osteoporosis Foundation estimates that 10 million people in the U.S. have osteoporosis and nearly 34 million more have osteopenia, which puts them at greater risk for osteoporosis.
Bone mineral density
(BMD) is related to bone strength. BMD testing is used to diagnose osteoporosis. BMD is measured with a test called a DXA scan. By measuring BMD, doctors can predict the risk of having a bone fracture.
A bone density scan, or test, should not be confused with a...
Teriparatide (Forteo) is self-injected into the skin. Because long-term safety is not yet established, it is only FDA-approved for 24 months of use. It reduces spine fractures in women with known osteoporosis, but reduction of hip fracture risk is currently unproven.
Who Should Take Forteo?
Men who have osteoporosis and postmenopausal women can take Forteo.
Forteo is not used to prevent osteoporosis or to treat mild osteoporosis.
This drug should be used if you've had at least one bone fracture due to thinning bones, you are at high risk of fractures, or you haven't responded to other osteoporosis therapies.